Maze Therapeutics Inc (MAZE)

Finanzdaten der Maze Therapeutics Inc-Aktie (MAZE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00%-	20.00	-	-	-
	3.18%48.04	46.55	38.06	32.97	36.47
Research and Development	2.32%34.94	34.15	27.57	25.19	28.11
Operating Income/Loss	80.90%-48.04	-26.55	-38.06	-32.97	-36.47
	84.76%-44.73	-24.21	-34.57	-30.09	-33.68
Attributable To Parent	84.76%-44.73	-24.21	-34.57	-30.09	-33.68
Basic Average Shares	9.46%59.00	53.90	-	45.78	43.80
Diluted Average Shares	9.46%59.00	53.90	-	45.78	43.80
Basic Earnings Per Share	68.89%-0.76	-0.45	-	-0.66	-0.77
Diluted Earnings Per Share	68.89%-0.76	-0.45	-	-0.66	-0.77